Hartford Healthcare Y (HGHYX)
| Fund Assets | 769.28M |
| Expense Ratio | 1.03% |
| Min. Investment | $250,000 |
| Turnover | 40.00% |
| Dividend (ttm) | 2.05 |
| Dividend Yield | 4.58% |
| Dividend Growth | n/a |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 27, 2024 |
| Previous Close | 45.41 |
| YTD Return | 3.49% |
| 1-Year Return | -12.27% |
| 5-Year Return | 5.86% |
| 52-Week Low | 38.92 |
| 52-Week High | 51.40 |
| Beta (5Y) | 0.66 |
| Holdings | 81 |
| Inception Date | Apr 28, 2000 |
About HGHYX
The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.
Performance
HGHYX had a total return of -12.27% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.37%.
Top 10 Holdings
47.73% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 12.37% |
| UnitedHealth Group Incorporated | UNH | 5.67% |
| Boston Scientific Corporation | BSX | 4.62% |
| Johnson & Johnson | JNJ | 4.47% |
| Merck & Co., Inc. | MRK | 4.12% |
| AbbVie Inc. | ABBV | 3.84% |
| Intuitive Surgical, Inc. | ISRG | 3.57% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.20% |
| Danaher Corporation | DHR | 3.05% |
| Cencora, Inc. | COR | 2.83% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2024 | $0.14994 | Dec 30, 2024 |
| Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
| Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
| Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
| Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
| Dec 10, 2019 | $2.36232 | Dec 11, 2019 |